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Abstract
Temporomandibular disorders are heterogeneous group of disorders 
involving the temporomandibular joint, masticatory muscles and 
associated structures. With a multifactorial origin, usually the patient with 
mandibular temporomandibular disorder reports multiple complaints, 
associated or not to comorbidities and non-repairing sleep. Anamnesis 
directed to the correct diagnosis is fundamental for the elaboration of a 
successful therapy. !e diagnostic process should be able to categorize the 
pain as well as identify the involved tissues in addition to pointing out 
the speci"c source of pain within that tissue system. !e steps to arrive 
at a correct diagnosis should cover: anamnesis, clinical evaluation for 
temporomandibular joint, the clinical examination through inspection of 
the cranial nerves, intra-oral evaluation and musculoskeletal examination, 
imaging tests, anesthetic block diagnosis, laboratory tests and evaluation 
of sleep pattern. !is process begins in the clinical history, presence or 
not of associated comorbidities, sleep pattern and other factors that may 
somehow contribute to the patient’s clinic. !is information supports the 
correct diagnosis and is essential for adequate and successful therapy.
/ŶƚƌŽĚƵĐƟŽŶ
!e temporomandibular joint (TMJ) is a synovial type joint composed 
from the head of the mandible and the temporal bone covered by 
"brocartilage. Among them, an oval and dense "brocartilaginous 
articular disc divides the joint into upper and lower part. !is disc has as 
main objective to prevent functional overload, a condition that can lead 
to temporomandibular dysfunction (TMD) [1].
!e origin of TMD is multifactorial, and may be traumatic, psychosocial 
(anxiety and depression), systemic diseases, altered intra-articular 
pressure and genetic factors. Typical clinical signs of TMD are idiopathic 
and episodic orofacial musculoskeletal pain and/or TMJ sounds (click, 
crackling), as well as limited movement of the mandible. !e cracks in the 
TMJ are a clinical sign of joint disc displacement, and although it is very 
frequent, it does not necessarily relates with pain, discomfort, or limitation 
of movement. TMD is a prevalent pathology that a#ects mainly women 
and can signi"cantly limit the quality of life of their patients. Success in the 
treatment depends on an accurate diagnosis, which can o$en be di%cult 
and challenging for even the most experienced professional. Patients 
o$en present multiple complaints, as well as reports of confusing signs 
and symptoms, which can result in a variety of diagnostic possibilities 
[1,2].
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!e detailed and directed clinical examination, through which the 
information collected enables the formation of data that will be analyzed by 
the professional, identifying and classifying any abnormality responsible 
for the signs and symptoms of the patient, are fundamental for the correct 
diagnosis [3]. !e diagnosis process should establish the category of pain 
(Somatic, Neuropathic or Psychogenic), determine the tissue system 
involved and identify the speci"c source of pain within that tissue system.
Content
Categories  of  Pain
!e diagnosis process should establish the category of pain (somatic, 
neuropathic or psychogenic), determine the tissue system involved and 
identify the speci"c source of pain within that tissue system. Somatic pain 
results from nociceptive stimuli, as excessive pressure, heat, cold, and 
chemical irritants, of normal structures that innervate the a#ected area. 
!ese stimulus can sensitize nociceptors, transmitting impulses to the 
central nervous system in which the perception of pain occur. !e pain is 
divided into super"cial and deep pain [3,4].
Super"cial somatic pain presents clear and stimulating quality, usually 
related to acute painful conditions, without di%culty for the diagnosis. 
Deep somatic pain has deaf, deep, depressive quality related to chronic 
pain. !is type of pain o$en exhibits central excitatory e#ects that may 
confuse the clinician, which may include autonomic e#ects and make 
diagnosis di%cult.
Neuropathic pain does not require noxious stimuli and can occur due 
to abnormalities or damage to the nervous system. It is divided into 
episodic (paroxysmal) and continuous. Episodic neuropathic pain is 
characterized by brief (paroxysmal) of intense pain, in short stabbing or 
shock, and of short duration. Occurs along the unilateral distribution of 
the involved nerve. (eg. trigeminal neuralgia). Continuous neuropathic 
pain is characterized by constant or burning pain, o$en accompanied by 
paresthesia or dysesthesia. (eg. atypical odontalgia). It should be noted 
that some continuous neuropathic pain may present involvement of the 
sympathetic autonomic nervous system [3,4].
Psychogenic pain is one that arises from psychological causes, is not 
caused by noxious stimuli or abnormalities of the nervous system and 
its psychological cause can’t be determined. It presents outstanding 
characteristics: the absence of an anatomical relationship between the 
source and the localization of pain, the dramatization of the symptoms, 
the absence of consistent reports and the inadequate response to the 
treatment [3,4].
ŝĂŐŶŽƐƟĐ'ƌŽƵƉƐ
Once the category of pain is established, the next step in the diagnostic 
process is to determine which group the pain originates from. Tissue 
systems can be divided into the following groups: intracranial structures, 
extracranial structures, musculoskeletal disorders, neurovascular 
disorders and neuropathic disorders. !e clinician should be able to 
identify, within these diagnostic groups, a speci"c pain syndrome based 
on the patient’s history and clinical "ndings. It is important to point out 
that when a patient presents with an orofacial pain complaint, it should 
"rst be evaluated for a possible cause of odontogenic pain.  If no dental 
etiology is found, a possible musculoskeletal pain should be considered. 
If both of the above categories are eliminated, the other systems should be 
evaluated [5,6].
Comprehensive  Assessment
A comprehensive assessment should include: the patient’s history, a 
complete physical examination, diagnostic tests and, if necessary, imaging 
and laboratory tests.
WĂƟĞŶƚ,ŝƐƚŽƌǇ
Taking the patient’s story is possibly the most important step in the 
evaluation process. Most cases of orofacial pain and temporomandibular 
disorder (TMD) can be diagnosed only on the basis of anamnesis, which 
is obtained through an appropriate interview and provides information 
about the problem. In order to do this, the clinician should be prepared 
to obtain a precise and complete history, and should use a previous 
questionnaire properly completed by the patient, which should be veri"ed 
with the clinical "ndings. !e American Academy of Orofacial Pain[7] 
recommends that a comprehensive story should contain: history of 
current illness, previous medical and dental history, review of systems, 
psychosocial history.
It is of fundamental importance that during anamnesis the patient is asked 
about the presence of some systemic pathology that may be a#ecting 
TMJ and triggering TMD, requiring a di#erential diagnosis prior to the 
establishment of an appropriate therapeutic course.
Among the main pathologies that may overlap the TMD is "bromyalgia. 
It is a chronic pain syndrome that causes fatigue and muscle weakness, 
characterized by generalized di#use pain, present for at least 3 months, 
on both sides of the body and above and below the waist, a#ecting mainly 
women. Pain is o$en more intense a$er sleep disturbances. Studies 
have shown that the prevalence of "bromyalgia in patients with TMD is 
relatively small (18.4%) when compared to the prevalence of myofascial 
pain in "bromyalgic patients (75.0%) [8].  Individuals who present both 
"bromyalgia and TMD report common clinical features such as type, 
quality, intensity and description of pain. While they di#er in self-report 
of functional capacity of work and general dissatisfaction with health [9]. 
Another important systemic change that deserves to be investigated is 
rheumatoid arthritis. Described as a chronic and relapsing in&ammatory 
disease of unknown cause, it a#ects multiple systems and may result in 
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destruction or ankylosis of the a#ected joints. !e main anatomical 
changes are observed in the joints of the hands, feet, wrists, elbows, ankles 
and knees, although the "rst clinical symptoms can be found in the TMJs 
bilaterally. !e diagnosis can be con"rmed with blood tests[10,11]. 
Physical  Exam
At the end of history, the clinician must have a rational idea of the nature 
of the patient’s problem and begin the exercise of di#erential diagnosis. 
!erefore, a comprehensive physical examination should be performed, 
seeking to locate the source of pain and identify a possible malfunction 
of the masticatory system. !e examination should include a general 
examination of the face, head and neck: musculoskeletal examination, 
intraoral evaluation, evaluation of cranial nerves.
!e inspection of the face, head and neck includes visualization and 
palpation, seeking to identify possible tumors, infections and/or other 
pathologies. One should also investigate scars indicative of trauma, 
signs of dermatological diseases that may suggest systemic disorders, 
look for areas with possible changes in sensitivity, and apply palpation 
of the lymph nodes chains (submentual, submandibular and super"cial 
cervical). Examination of the ear canal through otoscopy should also be 
part of this stage. Musculoskeletal examination consists of evaluation of 
temporomandibular joints (TMJ), chewing muscles and cervical joints. 
Musculoskeletal pain is classi"ed as deep somatic pain, usually described 
as constant and with periods of occasional exacerbations of well-de"ned 
pain. Challenge tests, functional activity and palpation of a#ected areas 
may increase pain [4].
Analysis  of  Dental  Occlusion
Classically occlusion was considered an important risk factor for 
temporomandibular dysfunction and has been widely investigated in 
recent years. Occlusal treatments such as occlusal adjustment in natural 
dentition, orthodontic treatments and occlusal plaques were used, 
based on the principle that unfavorable occlusal contacts could lead to 
neuromuscular changes [12]. However, no conclusions were drawn 
regarding the type of occlusal interferences that are detrimental to the 
function; what are the best indications and the best way to perform an 
occlusal adjustment, and whether the TMD is correlated with orthodontic 
treatment. Although a stable occlusion is the goal of these treatments, 
the lack of an ideal occlusion does not result in signs and symptoms of 
TMD [12-15]. Due to its multifactorial etiology, occlusion can  not be 
considered the most preponderant risk factor for TMD. Due to lack of 
scienti"c evidence, occlusal adjustment and orthodontic treatment should 
not be indicated to treat or prevent TMD. Currently, the relationship 
between occlusion and TMD is considered weak or non-existent, based 
on epidemiological data and systematic reviews [15]. 
ŝĂŐŶŽƐƟĐĂŶĚ/ŵĂŐŝŶŐdĞƐƚƐ
About 70% of the information needed to establish a diagnosis is 
obtained through physical examination and patient history. Sometimes 
a psychological evaluation can be important, allowing a better 
understanding of the complaints. Laboratory or imaging tests should only 
be indicated to con"rm the diagnosis, since they constitute complementary 
tests. Furthermore, TMJ region is di%cult to evaluate because of the 
large overlap of images. !e three-dimensional images complement the 
clinical examination. !e best techniques for visualizing TMJ structures 
are Magnetic Resonance Imaging (MRI) and Cone Bean Computed 
Tomography (CBCT) [5,6] (Figure 1). MRI has a good so$ tissue contrast 
allowing good visualization of both the articular disc and the supporting 
structures and adjacent chewing muscles. It is a non-invasive, non-
radiation examination with which it is possible to obtain several imaging 
planes through the water saturation and fat suppression features. It can 
provide high resolution images able to portray the physiological state of 
the articular disc with 95% accuracy in the sagittal and coronal sections. 
However, it´s a high-cost exam and requires sophisticated installations 
[5].
Figure 1: Magnetic Resonance Imaging (MRI) and Cone Bean Computed 
Tomography (CBCT)
CBCT provides accurate hard-tissue images that can be manipulated 
using speci"c so$ware. It reproduces three-dimensional maxillofacial 
mineralized tissues, with little distortion and reduced radiation dose when 
compared to conventional computed tomography (CT). It should be used 
to evaluate the bone quality, quantity and morphology of the components 
and structures associated with TMJ [6]. 
/ŶũĞĐƟŽŶƐĂƐĂDĞƚŚŽĚŽĨŝĂŐŶŽƐŝƐŽƌdƌĞĂƚŵĞŶƚŽĨdD
Injections can be used in orofacial pains for both diagnostic (diagnostic) 
and therapeutic (therapeutic injections) purposes. !is method allows us 
to inject medications allowing the control of pain. Currently, the most used 
solutions are local anesthetics, anti-in&ammatory drugs (corticosteroids 
and some non-steroidal ones) and sodium hyaluronate for intra-articular 
TMJ conditions. In order to perform this procedure, the anatomy and 
neuroanatomy of the area to be in"ltrated, as well as the therapeutic and 
adverse e#ects of the medication to be used should be adequately known. 
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Injections for diagnostic purposes consist of in"ltration of anesthetics 
without vasoconstrictor, promoting the immediate relief of pain for a 
short period of time.  So that it does not mask another area, possible pain 
source in a second complementary diagnostic injection.  !erefore, one 
should inject the least amount of anesthetic in each area and as previously 
stated, without vasoconstrictor. With this method we can identify trigger 
points in musculoskeletal pain, as well as trigger zones in neuralgias, in 
addition to de"ning if the pain is primary or secondary.  It is important 
to note that a solution based on 5% xylocaine can and should also be 
used as an anesthetic mouthpiece through mouthwash for the di#erential 
diagnosis in cases of pain of neuropathic origin, such as neuralgias in the 
glossopharyngeal nerve. O$en, we need to establish a di#erential diagnosis 
between an Eagle syndrome, which is calci"cation and lengthening of 
the styloid process, which may promote symptoms compatible with 
glossopharyngeal neuralgia, confusing even an experienced examiner in 
the area.
!e therapeutic injections promote pain relief. It is possible to use variable 
duration anesthetics, including high power (long duration) indicated for 
patients di%cult to control, promoting comfort and pain relief for hours 
or days. It is recommended to in"ltrate up to 1 tube of anesthetic allowing 
the performance of pain-free procedures [7].
/ŶĮůƚƌĂƟŽŶ ŽĨ ^ƚĞƌŽŝĚ ŶƟͲ/ŶŇĂŵŵĂƚŽƌŝĞƐ ĂƐ Ă DĞƚŚŽĚ ŽĨ
Treatment  of  TMD
!e in"ltration of steroid anti-in&ammatory drugs locally has the main 
advantage of providing the action of the drug without the patient su#ering 
the systemic e#ects of it. !ey can be used to treat muscles, ligaments, 
joints and tendons. !e main anti-in&ammatories suggested for these 
procedures are described in Table 1 [16]. 
Table 1: Suggestion of anti-in&ammatory for local Injection
3.10 Pericapsular In!ltration of Steroidal Anti-In"ammatory as a 
Method of Treatment of TMD
It should be indicated in cases of adjunctive therapies of TMJ capsulitis, 
refractory to the conventional protocol. For this procedure, the celestone 
or celestone soluspan should be used as an election measurement. !e 
medication should be injected externally into the subcutaneous capsule 
using an insulin needle and syringe (8 or 13mm in length and 30G), 
aiming to spread the product over a larger area in all directions (needle 
fan movement). Initially, between the "rst and third day the patient may 
present a slight worsening of the symptoms due to the trauma of the 
injection. If this happens, it is suggested to prescribe analgesic and / or 
NSAIDs for a short period of time, for immediate relief of symptoms. A$er 
the third day the patients begin to show improvement of the symptoms. 
!e recommended dosage is 0.5 to 1 mL and can be reapplied at intervals 
of 30 to 60 days, in cases of very di%cult control and extreme safety of the 
prescription. It is recommended to in"ltrate this medication peri-capsular 
at least twice before opting for intra-capsular in"ltrations. !is fact is due to 
avoid the deleterious e#ects of corticosteroids on the synovial membranes 
of the TMJ, as well as in the degradation of the "brocartilage coating of 
the articular surfaces.  !is avoids compromising the lubrication system 
of the joint and allows us to explore the anti-in&ammatory and analgesic 
properties as a consequence of this medication [16]. 
!e realization technique is simple and easy to perform. It is initiated by 
antisepsis and alcohol application in the region to be in"ltrated, the ear 
region must be protected by means of a tamponade. An anesthetic spray 
is then applied to promote cryotherapy analgesia (&uoromethane or ethyl 
chloride), then follow the puncture, aspiration and injection sequence of 
the medication [7] (Figure 2).
DRUG TECHNICAL CHARACTERISTICS CONCENTRATION
DEPO-MEDROL ® METHYLPREDNISOLONE ACETATE Crystalline, dissolves slowly, long lasting 40/80 mm por cc
CELESTONE SOLUSPAN ® BETAMETHASONE ACETATE AND BETAMETHASONE DISODIUM PHOSPHATE
Crystalline and aqueous solution, 
fast anti-in&ammatory action and 
long duration
6 mm por cc
DECADRON ® DEXAMETHASONE Short term 4 mm por cc
ARISTOSPAN ® TRIANCINOLONE HEXACETONIDE
Two phases with more e#ective 
and long action when compared 
to celestone soluspan
20 mm por cc
CELESTONE ® BETAMETHASONE
Aqueous solution, fast anti-
in&ammatory action and short 
duration
4 mm por cc
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Figure 2: Pericapsular in"ltration of steroidal anti-in&ammatory
!is procedure can generate as an adverse e#ect the dissolution of fats 
causing the patient to report a sensation of perceiving the TMJ more 
evident. Another important consideration is that the patient may present 
an allergy to the in"ltrated drug and may manifest anaphylactic shock or 
intense allergic reaction.  Do not forget to carry out an anamnesis of a 
broad and comprehensive past history.
/ŶƚƌĂĐĂƉƐƵůĂƌ /ŶĮůƚƌĂƟŽŶ ŽĨ ^K/hD ,z>hZKEd EͬKZ
^ƚĞƌŽŝĚĂůŶƟͲ/ŶŇĂŵŵĂƚŽƌǇĂƐĂDĞƚŚŽĚŽĨdƌĞĂƚŵĞŶƚŽĨdD
!e patient should be open-mouthed and wearing gauze, then palpate the 
posterior region of the jaw head. Use syringe and insulin needle, at a 450 
angle to the skin. !e needle should be inserted in the anterior-anterior 
direction, penetrating 1.0 to 1.5 cm, aspirate and then inject about 1 mL 
of anesthetic (Figure 3). 
Figure 3: JANUZZI E - Intracapsular injection of steroidal anti-
in&ammatory
Sodium Hyaluronate may be in"ltrated in the TMJ region to promote 
viscosity uptake of the joint [7] (Figure 4).
Figure 4: Viscosupplementation of the temporomandibular joint with 
Sodium Hyaluronate (HS).
Pain and in&ammation should be avoided in order to prevent degenerative 
conditions. Although the conservative approach is always recommended, 
in more advanced cases intra - capsular corticoid in"ltration will be 
necessary at a maximum quarterly frequency. !e ideal is the minimum 
of this type of in"ltration, or use it together with a viscosupplementation, 
seeking to minimize its deleterious e#ects as previously described (Figure 
5) [7]. 
Figure 5: Viscosupplementation of ATM with Sodium Hyaluronate (HS), 
associated with intra-articular steroidal anti-in&ammatory.
3.12 Muscle Injection as a Method of Diagnosis or Treatment of TMD
Hypersensitive nodules within a skeletal muscle are called myofascial 
trigger points, while trigger areas of neuropathic pain (eg, trigeminal 
neuralgia) are called trigger zones. !e trigger point is said to be latent 
when it does not generate referred pain and is called active when it causes 
referred pain in situations of muscle stimulus or function (chronic skeletal 
muscle pain) [17].
!e muscular injection in the regions of trigger points, also called 
muscular needle or myofascial trigger point injections, aims to promote 
mechanical rupture of the muscle nodule, improve local blood supply 
and tissue oxygenation, as well as avoid pain and discomfort during 
physiotherapy sessions [18].
!e recommended anesthetic solution for this procedure is the anesthetic 
without vasoconstrictor. In cases of refractory or di%cult to control it is 
possible to further recommend the in"ltration of botulinum toxin, which 
reduces substance P, just as it seems to act in other excitatory peptides for 
pain [19].
For this procedure is very important the knowledge of anatomy 
neuroanatomy, and the main anatomical accidents present. Among them 
we can mention:
A.   Masseter muscle: Parotid gland in which the facial nerve branch 
passes, responsible by muscles of facial expression. If it is reached 
during the procedure, the patient may be le$ without closing the 
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eyes until the anesthetic action completely passes (Figure 6).
B.   Temporal muscle: !e super"cial temporal artery is present in the 
form of branches in a large part of this muscle.
C.   Sternocleidomastoid muscle: we must pay attention to the internal 
jugular vein and external carotid artery. Avoid injecting bilaterally 
so as not to run the risk of an accident when injecting, it is reaching 
the interior of these blood vessels, which could lead to a lipothymia. 
It should be drawn externally in a tweezer palpation with the thumb 
and fore"nger so as to isolate the muscle well and not to run the risk 
of reaching one of these blood vessels.
D.   Trapezius muscle: traction it upwards, in order to isolate the muscle 
well, so as not to run the risk of reaching one of these blood vessels, 
besides not approaching the lung, avoiding a possible perforation of 
this, minimizing the risk of a possible pneumothorax.
Figure 6: Anatomy and the main anatomical accidents present - A.Muscle.
Masseter - B. Muscle Temporal - C. Muscle Sternocleidomastoid - D. 
Muscle Trapézio.
!e technique consists of identifying and demarcating the trigger point 
region, then promoting the asepsis and application of iodinated alcohol. 
!e anesthetic is then sprayed with ethyl chloride or &uoromethane fol-
lowed by puncture, aspiration, in"ltration and then, muscle stretching is 
promoted [19]. 
ůŽĐŬĂŐĞ ŽĨ ƚŚĞ ƵƌŝĐůĞ dĞŵƉŽƌĂů ĂŶĚ DĂƐƐĞƚĞƌ EĞƌǀĞƐ ĂƐ Ă
Method  of  Diagnosis  or  Treatment  of  TMD
!e auriculotemporal nerve is responsible for about 80% of the inner-
vation of TMJ and is therefore the main responsible for the sensation of 
pain in this region. !e masseteric nerve is responsible for the secondary 
innervation of TMJ, about 20% of the innervation of this joint (Figure 7). 
Although less invasive, the blocks of these nerves are less e#ective than 
the intra-articular anesthetic injection. For this procedure, anesthetics of 
short or long duration can be used, depending on the objective that is 
wanted to reach (Table 2).
Table 2: Suggestion for local anesthetic
Figure 7: Blockage of the temporal and masseterinary atria respectively.
Technique: Antisepsis should be performed with disinfectant, then clean-
ing with 70% alcohol or iodine from the region to be injected. Use syringe 
with re&ux, provided with a long needle. For the auriculotemporal nerve 
block the needle must be inserted completely between the tragus / lobe of 
the ear, in the postero / anterior direction, with medial path, passing be-
hind the head of the mandible. For the masseterine nerve block, we must 
locate the mandibular notch with a patient with the mouth half open; the 
needle must be inserted completely anterior to posterior at a 45º angle in 
this region. !e medication should be injected slowly and gradually, to 
generate the least discomfort possible for the patient [19].
It is important to consider that lidocaine has a half-life of 10 to 30 minutes, 
mepivacaine for 30 to 60 minutes, whereas marcaine promotes a half-life 
of 2 to 8 hours and also has a higher toxicity power.
ŽŶƚƌĂŝŶĚŝĐĂƟŽŶƐŽĨ/ŶũĞĐƟŽŶƐ
Do not inject medications into infected regions or those individuals who 
are allergic to the medication being in"ltrated. !e antisepsis of the area 
should always be performed with the use of iodinated alcohol to avoid 
contamination and promote a safe procedure. Drug interactions are also 
an important factor in contraindications, especially in cases of patients 
who have su#ered a stroke, present uncontrolled systemic arterial pres-
sure (BP), or who may present an increase in BP due to anxiety prior to 
the procedure [19] (Figure 8). 
Anesthetic Type of lock Concentration DoseMl Mg
LIDOCAINE
In"ltration / 
Diagnosis
1%
2%
5 -10
2,5 - 5
MEPIVACAINE
In"ltration / 
Diagnosis / 
!erapy
3% 2,5 - 5
MARCAINE
(with and without 
epinephrine)
In"ltration / 
!erapeutics
0,25 %
0,5 %
5 – 60
5 - 30
125 – 150
25 - 150
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Figure 8: Abscess in ATM due to an intra-articular fracture of the man-
dible head.
Laboratory  Tests
When there are signs and symptoms suggestive of systemic disease, 
other tests such as blood count, urine test and synovial &uid may be 
indicated (Figure 9). Such diseases may include a variety of connec-
tive tissue disorders, metabolic disorders, infectious diseases, hema-
tological disorders, nutritional de"ciencies and even malignant tu-
mors. Speci"c tests should be requested for selected patients, as long 
as the result can a#ect the diagnosis and treatment to be performed, 
making it necessary to refer to the appropriate specialist physician [4]. 
 
Figure 9: Histopathological analysis of TMJ (sagittal cut).
^ůĞĞƉǀĂůƵĂƟŽŶ
!e relationship between pain and sleep is bidirectional, studies have 
shown that chronic pain leads to sleep fragmentation whereas poor sleep 
quality also in&uences the perception of pain.  !us, the investigation, rec-
ognition and treatment of a sleep disorder as a possible aggravating factor 
of patient’s pain should be part of the diagnostic protocol for temporoman-
dibular dysfunction [20,21]. Gold standard for evaluating patient sleep is 
the complete polysomnography (PSG) performed in a specialized sleep 
clinic.  It is a highly complex examination in which the patient sleeps in a 
specialized clinic and, during the night, electroencephalographic markers, 
respiratory e#ort, oxyhemoglobin saturation levels, heart rate, as well as 
the level of relaxation muscular are measured. !rough the polysomno-
graphic record, a very detailed report of the quality of sleep of the patient 
is provided, as well as the presence or absence of possible sleep disorders. 
However, although extremely e#ective, it is a high-cost, di%cult-to-access, 
and expensive exam [22]. 
Currently, some questionnaires can also be used in clinical practice in or-
der to predict a possible change in the patient’s normal sleep pattern and, 
if pertinent, to refer the individual for a more detailed analysis and treat-
ment of this condition. Among the validated and most used questionnaires 
are the following: Epworth’s sleepiness scale (evaluates excessive sleepiness 
during the day); Pittsburgh Questionnaire (assesses sleep quality); and, 
more recently, mobile apps. !is assess the presence or absence of snoring, 
its intensity and percentage for a full night. Among them, SnoreLab and 
NoSAS stands out for its ease of access and simplicity of use, however still 
lack of a broad validity as a standalone diagnostic method.
&ŝŶĂůŽŶƐŝĚĞƌĂƟŽŶ
Temporomandibular dysfunction is a prevalent pathology that has an 
important impact on the quality of life of its patients. !e anamnesis of 
the patient with clinical signs and symptoms should investigate intra-oral 
conditions, musculoskeletal structures, clinical metabolic condition, as 
well as their quality of sleep. !e di#erential diagnosis de"nes the best 
therapy to be adopted, and it´s determinant for the ultimate success of the 
treatment adopted.
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